Billions more euros to re-invest in better healthcare thanks to biosimilar medicines

13 December 2022

Ready in a crisis: Medicines for Europe commits at one year anniversary of HERA

8 December 2022

2022 Health at a Glance Report highlights the need to rethink investments in health after the COVID-19 pandemic

5 December 2022

Giving medicines a new life: EU should foster patients’ access to Value Added Medicines

30 November 2022

Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies

16 November 2022

Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition

26 October 2022

PHARMA BOARDROOM – Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry

19 October 2022

Victor Mendonça, chair of the Generic Market Access Committee at […]

MANUFACTURING CHEMIST – EU supply chain regulation: what will it mean for companies attending CPHI?

17 October 2022

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt […]

Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

PHARMACEUTICAL TECHNOLOGY – Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]